What is Medicocon?
Established in 2018, Medicocon is at the forefront of the InsurTech sector in Hong Kong. The company leverages blockchain technology to streamline the insurance claims process and enhance medical consultation experiences for its clients. Medicocon has garnered recognition through numerous local and international awards, validating its innovative approach. Its operational network spans Hong Kong Island, Kowloon, and the New Territory, encompassing partnerships with a wide array of insurance providers and healthcare facilities, including medical clinics, physiotherapy centers, Chinese Herbalist clinics, and dental practices.
How much funding has Medicocon raised?
Medicocon has raised a total of $6.8M across 1 funding round:
Series A
$6.8M
Series A (2024): $6.9M with participation from G & M Capital, ParticleX, and HSBC Asset Management
Key Investors in Medicocon
G & M Capital
G & M Capital is a venture capital firm that operates in the Venture Capital & Private Equity industry, likely focusing on early-stage investments.
ParticleX
ParticleX is an accelerator and investor dedicated to fostering the growth of tech startups, particularly in areas like Big Data, AI, IoT, Blockchain, and Robotics.
HSBC Asset Management
HSBC Asset Management is a global investment firm offering a comprehensive range of asset management services, with a focus on responsible investing and sustainability.
What's next for Medicocon?
The recent major strategic investment signals a pivotal growth phase for Medicocon. This capital infusion is expected to fuel further expansion of its service offerings and technological development, particularly in enhancing its blockchain-based solutions for insurance and healthcare. The company's focus on seamless integration and automatic processing positions it for significant scaling within the InsurTech market, potentially attracting further backing as it solidifies its market presence and technological leadership.
See full Medicocon company page
